Molecular Devices was founded in Silicon Valley, USA in 1983 and launched its * microplate reader in 1987. Since then, Molecular Devices has continuously expanded its solutions in biological analysis and detection systems through its relentless research and cooperation.

Molecular Devices provides you with high-performance analytical detection systems to accelerate and improve drug development and basic life science research. Our products can almost meet all the needs of throughput, content, and budget. In addition to research institutions and departments, we also assist pharmaceutical and biotechnology companies in understanding various biological functions at the molecular, cellular, and systemic levels, and researching and developing new therapeutic methods.

Molecular Devices has acquired Universal Imaging Corporation (2002), Axon Instruments (2004), Blueshift Technologies (2008), and Genetix (2012) in recent years, further expanding the company's product range. Now, Molecular Devices, Leica, AB Sciex, Beckman Coulter and other companies are all affiliated with Danaher Group. Our product line includes: microplate reader series, liquid processing systems, electrophysiological detection systems, neurobiological instruments and software, high content cell imaging systems, biochar scanners and software, Threshold systems, screening reagents, clone selection systems, etc. Among them, the microporous plate reading machine series covers reading modes such as light absorption, fluorescence intensity, chemiluminescence, fluorescence polarization, time polarization fluorescence, as well as endpoint detection, spectral scanning, fast and slow kinetics detection methods.

Molecular Devices is headquartered in Sunnyvale, the center of Silicon Valley in the United States, and has multiple representative offices in countries including the United States, France, the United Kingdom, Germany, China, South Korea, Japan, Brazil, and more. Our philosophy is to continuously meet user needs while always focusing on their success.